Difference between revisions of "Team:Pitt/Description"
Line 89: | Line 89: | ||
<tr> | <tr> | ||
<td colspan="3" class="td50"><h4>Cell-free Extracts</h4><br/>The use of cell-free extracts for sensors allows us to solve several problems at once. First of all, by using the natural amplification of both transcription and translation <i>in vitro</i>, extremely small amounts of analyte can be detected. Furthermore, it was recently shown that these cell extracts retain their function when freeze-dried on paper, which allows for easy transport of the completed sensor.(<a href="http://www.cell.com/abstract/S0092-8674(14)01291-4">Pardee 2014</a>)<div><button class="expander">Click to read more...</button></div> | <td colspan="3" class="td50"><h4>Cell-free Extracts</h4><br/>The use of cell-free extracts for sensors allows us to solve several problems at once. First of all, by using the natural amplification of both transcription and translation <i>in vitro</i>, extremely small amounts of analyte can be detected. Furthermore, it was recently shown that these cell extracts retain their function when freeze-dried on paper, which allows for easy transport of the completed sensor.(<a href="http://www.cell.com/abstract/S0092-8674(14)01291-4">Pardee 2014</a>)<div><button class="expander">Click to read more...</button></div> | ||
− | <br/><span style="display: none;">Cell-free extracts are essentially | + | <br/><span style="display: none;"> <br/><img style="width: 50%; border: 2px solid black; margin: 15px;" src="https://static.igem.org/mediawiki/2015/d/d6/Cellfreeextractspicturepitt.png"/><br/>Cell-free extracts pose a significant advantage over cell-based assays in that synthetic gene networks can easily be used without extensive cloning, as shown above. At the most basic level, cell-free extracts are essentially lysed cells. In fact, it was in cell-free extracts that the genetic code was discovered, as it allowed for easy control of translation. Since 1953, significant advancements have been made in this technology, providing extremely fine control over both transcription and translation. In its simplest form, a cell-free extract made from <i>E. coli</i> will contain all the components of the prokaryotic cell, except for the cell wall, the membrane, and the chromosomal DNA attached to the membrane. While this extract will be able to both transcribe DNA, and translate the resulting RNA, both processes occur at very low rates. During cell growth, a cell will produce and reuse a variety of small molecules, including but not limited to nucleotide triphosphates (NTPs) and amino acids. Both of these are essential to <i>in vitro</i> transcription and translation. However, once the chromosomal DNA is removed, the extract retains very little of its ability to create small molecules and create high energy molecules from energy sources such as glucose. With this realization, a number of improvements to the cell-free extract were made, by adding the necessary components to the final reaction mixture. The amino acids and NTPs are added in great excess, which not only provides the starting materials for RNA and protein synthesis, but also increases the thermodynamic drive for the synthesis of macromolecules. In addition, creatine kinase is added along with creatine phosphate as a way of regenerating high energy molecules such as ATP from ADP. After these modifications to the cell-free extract protocol, there was about a (number) increase in the rate of production of protein from extracts. However, it was soon realized that the majority of ribosomes were still bound to mRNAs from the lysed cell, some of which stalled during translation, which diverted some of the energy from producing the protein of interest to producing short peptides and other proteins. To counteract this source of contamination, an additional incubation step was added, followed by a dialysis step to free as many of the ribosomes as possible. Th final modifications to the currently accepted cell-free extract protocol were made in 2006 (<a href="http://www.ncbi.nlm.nih.gov/pubmed/16487613">Kim 2006</a>), and our group used a similar method. However, the goal of most groups is to produce as much protein as possible, for which they require an extract as free of other proteins as possible. For the purpose of this project, proteins that regulate transcription are needed in the cell extract. One way of achieving this is by purifying the protein from a cell extract, then adding to the final reaction mixture. However, a simpler approach is to induce the protein of interest directly in the cells from which the extract is made. By choosing this approach, the number of steps required for the production of our "sensor extracts" (SE) was greatly reduced. Currently, the entire production process requires 3 days, and the final cost of a single sensor is less than 50 cents. To see more, click <a href="2015.igem.org/Team:Pitt/Protocols">here</a>. For sensor extracts, it is typical to include proteins that allow for the modulation of transcriptional activation in the presence of an analyte, while the final reaction mix contains a DNA construct that contains the appropriate promoter followed by a reporter gene (typically a fluorescent protein such as GFP). <div><button class="minimizer">Click to read about other aspects of the project...</button></div><span> |
</td> | </td> | ||
Revision as of 03:45, 19 September 2015
Cheap biosensors based on cell-free extracts
Pitt's 2015 iGEM team investigated the possibility of using cell-free extracts as a method of detecting extremely small concentrations of biomolecules. Furthermore, these sensors were tested after being freeze-dried on paper, to test the feasibility of mass-producing and distributing cheap sensors worldwide. While the ideas tested in this project can be applied to sense an almost unlimited number of biomolecules, we focused on three major sensors.
Project Idea and MotivationThe ability to detect small concentrations of molecules accurately without the use of lab equipment is a huge step in creating portable sensing devices. While many extremely sensitive methods have been developed, there are very few that are amenable to work in the field, or at home as a consumer product. This project focuses on creating methods that allow for simple and quick detection of biomolecules without the use of laboratory instruments. |
|||||
Cell-free ExtractsThe use of cell-free extracts for sensors allows us to solve several problems at once. First of all, by using the natural amplification of both transcription and translation in vitro, extremely small amounts of analyte can be detected. Furthermore, it was recently shown that these cell extracts retain their function when freeze-dried on paper, which allows for easy transport of the completed sensor.(Pardee 2014) |
Clear Responses: Amplification and QuenchingOne of the key aspects of creating a reliable and useful sensor is having a clear yes/no response. A good example of this is the at-home pregnancy test, where 2 lines indicates pregnancy, and 1 line indicates no pregnancy. While it is impossible to remove all outliers, we have been working on a system that will amplify positive signals, while quenching noise. |
||||
Estrogen SensorWhile it has been shown that transcription in cell-free extracts can rely on RNA polymerases sensitive to small molecules (Pardee 2014), our team decided to test the viability of using such polymerases in our cheap, home-made sensor extracts, rather than in expensive, commercially available extracts. In doing so, we used a part from CMU's iGEM team, the estrogen-sensitive T7 RNA polymerase. |
Protease SensorThe second sensing system we have designed relies on transcriptional repressors. By creating a synthetic repressor that gets cleaved by a specific protease, the extract we create will be sensitive to the protease. This can be used to detect breast and colorectal cancer biomarkers such as MMP-2 and MMP-9 in patients' urine.(Coticchia 2011) |
Three-Hybrid Versatile SensorThis project aims to develop the full versatility that paper-based sensors can have. This system uses the idea of a three-hybrid system, where one part binds the promoter, another part is a subunit of E. coli RNA Polymerase, and the analyte of choice provides the bridge that recruits the RNAP to the DNA. For this system, we chose two analytes: VEGF-A, which is a small dimeric protein involved in many cancers, and anti-MUC1 antibodies, which are established prognostic marker for favorable outcomes of lung, breast, pancreatic, and colon cancers (Hirasawa 2000, von Mensdorff-Pouilly 2000, Hamanaka 2003, Kurtenkov 2007). |